Search
for
Sort by
Research 211–240 of 1000+
- 46,XY DSD due to impaired androgen production
- A review of the treatment of male pattern hair loss
- Hair disorders in patients with cancer
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Mixed “Antiandrogenic” Chemicals at Low Individual Doses Produce Reproductive Tract Malformations in the Male Rat
- The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- 5α-Reduced glucocorticoids: a story of natural selection
- Endocrine-skin interactions
- Spinal and bulbar muscular atrophy: pathogenesis and clinical management
- Adipose mesenchymal stem cells combined with platelet-rich plasma accelerate diabetic wound healing by modulating the Notch pathway
- Role of insulin resistance and diet in acne
- Anabolic-androgenic steroids and cardiovascular risk
- 5-Alpha reductase deficiency
- Current evaluation of amenorrhea
- The hair cycle and its regulation
- Acquired scalp alopecia. Part II: A review
- Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat
- Generation of Cashmere Goats Carrying an <i>EDAR</i> Gene Mutant Using CRISPR-Cas9-Mediated Genome Editing
- Gender-Affirming Hormone Therapy for Transgender Females
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- LPA3, a unique G protein-coupled receptor for lysophosphatidic acid
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia